Investors can now trade exposure to Anthropic’s implied valuation before its IPO through a European exchange-traded product. Launched on October 13, 2026, 21shares’ pre-IPO Anthropic ETP, the 21shares Anthropic Synthetic ETP, uses derivatives to provide continuous, unleveraged exposure to the private AI company’s valuation.
Key takeaways
- CLAU is Europe’s first ETP offering pre-IPO exposure to Anthropic.
- The product tracks valuation exposure through swaps tied to a Kaiko benchmark.
- Its total expense ratio is 1.00%, with a separate 2.00% exit fee.
According to the launch release published by Taiwan News, the product brings private-market valuation exposure into an exchange-traded format for traditional investors. A dedicated issuer, 21shares x FalconX Limited, supports the synthetic structure.
21shares’ pre-IPO Anthropic ETP lists on Vienna MTF
The product trades under ticker CLAU on Vienna MTF, operated by Wiener Börse. Its listed currency is EUR, and its inception date is October 13, 2026.
The fee schedule sets a 1.00% total expense ratio and a 2.00% exit fee. The product’s ISIN is CH1606386675.
The launch release describes CLAU as Europe’s first ETP giving investors exposure to Anthropic’s implied valuation ahead of its initial public offering. The exposure is synthetic and unleveraged, with performance linked to derivatives rather than a conventional stock-market listing.
How the synthetic exposure works
The ETP obtains its underlying exposure through total return swaps on the Kaiko Anthropic USD Reference Rate (USDT) (London) index. Kaiko derives the index’s daily reference price from Binance’s Anthropic perpetual futures.
The swap contracts track the performance of those listed perpetual futures without leverage. This mechanism connects the exchange-traded product to the valuation implied by pre-IPO perpetual-market trading.
The dedicated special purpose vehicle, 21shares x FalconX Limited, was created to issue synthetic exposure and operates as a standalone structure. The release describes it as an expansion of 21shares’ product-engineering capabilities.
FalconX supplies derivatives capabilities, Kaiko the benchmark
The structure pairs 21Shares’ ETP engineering expertise with FalconX’s prime brokerage balance sheet, together with its multi-venue execution capabilities and derivatives desk. Kaiko supplies the independent reference price used for Anthropic’s implied valuation.
Anne-Claire Maurice, Managing Director, Indices and Analytics Data at Kaiko, said the benchmark draws on actual pre-IPO trading in perpetual markets. Its role is to give the product’s net asset value an objective, transparent price from an independent, institutional-grade benchmark administrator.
The release also describes the structure as a repeatable route for delivering multi-asset strategies, pre-IPO exposure and yield-bearing derivative structures to investors.
Bringing private AI valuations into an exchange-traded format
The pre-IPO Anthropic ETP is designed to let traditional investors access private-market valuation exposure through a familiar trading format. Duncan Moir, President and Chief Investment Officer at 21shares, framed the launch as a response to an access gap for investors interested in private AI companies.
“We are taking the structural tools developed in digital assets and applying them to alternative and multi-asset investing,” Moir said.
Austin Reid, Chief Commercial & Strategy Officer at FalconX, described the launch as a differentiated product responding to investor demand for access to particular market segments.
Article produced with the assistance of artificial intelligence and reviewed by the editorial team.